Company: CRVO
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001437749-25-007829
Chunk: 33

Company: CervoMed Inc.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1A
Chunk 33
---
 Executive Officers

The table below sets forth, as of March 15, 2025, certain information concerning our current executive officers.

  Name                                Age      Position                                                                   
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  John Alam, M. D.                     63      President and Chief Executive Officer (Principal Executive Officer)        
  William Elder                        42      Chief Financial Officer and General Counsel (Principal Financial Officer)  
  Robert J. Cobuzzi, Jr., Ph. D.       60      Chief Operating Officer                                                    
  Kelly Blackburn, M. H. A.            61      Senior Vice President, Clinical Development                                

Our Scientific Advisory Board

We have assembled a highly qualified SAB comprised of thought leaders in the fields of cell biology, intracellular signal transduction, neurotherapeutics, and translational neuroscience.

  Name                                 Affiliated Entity                                                                                                                                                                                     
  Ole Isacson, Dr. Med. Sci.           Professor of Neurology at Harvard Medical School, Founding Director of the Neuroregeneration Research Institute at McLean Hospital                                                                    
  Lewis Cantley, Ph. D.                Professor of Cell Biology at Harvard Medical School. Prior to this appointment, he was the Margaret and Herman Sokol Professor and Meyer Director of the Sandra and Edward Meyer Cancer Center at...  
  Jeffrey Cummings, M. D., Sc. D.      Joy Chambers-Grundy Professor of Brain Science and the Director of the Chambers-Grundy Center for Transformative Neuroscience at the UNLV School of Integrated Health Sciences. Prior to UNLV, Dr...  
  Heidi McBride, Ph. D.                Canada Research Chair in Mitochondrial Cell Biology, Professor in the Department of Neurology and Neurosurgery at McGill University                                                                   

Corporate Information

Our History

We were originally incorporated under the laws of the State of Nevada on January 10, 1995, and reincorporated under the laws of the State of Delaware on June 18, 2015. On August 16, 2023, we completed the Merger, which was treated as a "reverse recapitalization" under U. S. GAAP pursuant to which EIP’s historical results of operations replaced the Company's for all periods prior to the Merger. Immediately following the closing of the Merger, we changed our name from "Diffusion Pharmaceuticals Inc." to "CervoMed Inc."

Where to Find Us

Our principal corporate office is located at 20 Park Plaza, Suite